Australia Clinical Trial Equipment & Ancillary Solutions Market Size & Outlook
Related Markets
Australia clinical trial equipment & ancillary solutions market highlights
- The Australia clinical trial equipment & ancillary solutions market generated a revenue of USD 89.0 million in 2024 and is expected to reach USD 208.6 million by 2033.
- The Australia market is expected to grow at a CAGR of 9.9% from 2025 to 2033.
- In terms of segment, supply/logistics was the largest revenue generating type in 2024.
- Supply/Logistics is the most lucrative type segment registering the fastest growth during the forecast period.
Clinical trial equipment & ancillary solutions market data book summary
| Market revenue in 2024 | USD 89.0 million |
| Market revenue in 2033 | USD 208.6 million |
| Growth rate | 9.9% (CAGR from 2025 to 2033) |
| Largest segment | Supply/logistics |
| Fastest growing segment | Supply/Logistics |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Sourcing, Supply/Logistics, Service |
| Key market players worldwide | Woodley Equipment Company, PAREXEL, Thermo Fisher Scientific Inc, Cadila Pharmaceuticals, United Parcel Service Inc Class B, Ancillare, Imperial CRS, Emser, Quipment, Myonex, Yourway |
Other key industry trends
- In terms of revenue, Australia accounted for 2.8% of the global clinical trial equipment & ancillary solutions market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China clinical trial equipment & ancillary solutions market is projected to lead the regional market in terms of revenue in 2033.
- South Korea is the fastest growing regional market in Asia Pacific and is projected to reach USD 105.7 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Clinical Trial Equipment & Ancillary Solutions Market Scope
Clinical Trial Equipment & Ancillary Solutions Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Yourway | View profile | 51-100 | Allentown, Pennsylvania, United States, North America | http://www.yourway.com |
| Myonex | View profile | 101-250 | Horsham, Pennsylvania, United States, North America | https://www.myonex.com/ |
| Quipment | View profile | 51-100 | Nancy, Lorraine, France, Europe | https://www.quipment.fr |
| Emser | View profile | 51-100 | Leiden, Zuid-Holland, The Netherlands, Europe | https://www.emsere.com |
| Imperial CRS | View profile | 251-500 | Grand Rapids, Michigan, United States, North America | http://www.imperialcrs.com |
| Ancillare | View profile | 251-500 | Horsham, Pennsylvania, United States, North America | https://www.ancillare.com |
| Cadila Pharmaceuticals | View profile | 5001-10000 | Ahmedabad, Gujarat, India, Asia | http://cadilapharma.com |
| PAREXEL | View profile | 10001+ | Waltham, Massachusetts, United States, North America | http://www.parexel.com |
| United Parcel Service Inc Class B | View profile | 500000 | 55 Glenlake Parkway, N.E. Atlanta, Atlanta, GA, United States, 30328 | https://www.ups.com |
| Woodley Equipment Company | View profile | 101-250 | Bolton, Bolton, United Kingdom, Europe | http://www.woodleyequipment.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
Australia clinical trial equipment & ancillary solutions market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial equipment & ancillary solutions market will help companies and investors design strategic landscapes.
Supply/logistics was the largest segment with a revenue share of 36.74% in 2024. Horizon Databook has segmented the Australia clinical trial equipment & ancillary solutions market based on sourcing, supply/logistics, service covering the revenue growth of each sub-segment from 2021 to 2033.
Australia held 11.5% of market share of Asia Pacific clinical trial equipment & ancillary solutions market owing to factors such as presence of key opinion leaders across each therapeutic area, quality medical research infrastructure and a skilled workforce, well-established healthcare system, favorable R&D tax incentives for the clinical trials, and a fast regulatory pathway.
Various International and local biotechnology, pharmaceutical, and medical device companies arrange a full procedure of clinical trials in the Australia, from Phase I to Phase IV, accounting for 18% are for Phase I, 22% are from Phase II, 40% are for Phase III, and around 4% are for Phase IV.
The therapeutic research areas include Oncology, Type 2 Diabetes, Pain, Non-Small Cell Lung Cancer, CNS, Infectious Disease, Solid Tumours, Hepatitis C, and Metabolic Disorders to name a few. This is expected to boost the market growth in the region.
Reasons to subscribe to Australia clinical trial equipment & ancillary solutions market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia clinical trial equipment & ancillary solutions market databook
-
Our clientele includes a mix of clinical trial equipment & ancillary solutions market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia clinical trial equipment & ancillary solutions market , including forecasts for subscribers. This country databook contains high-level insights into Australia clinical trial equipment & ancillary solutions market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Australia clinical trial equipment & ancillary solutions market size, by type, 2021-2033 (US$M)
Australia Clinical Trial Equipment & Ancillary Solutions Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
